title: Present and future role of FDG-PET/CT imaging in the management of gynecologic malignancies.
abstract: Integrated positron emission tomography/computed tomography (PET/CT) with 2-[18F]fluoro-2-deoxy-D-glucose (FDG) is a useful technique for acquiring both glucose metabolic and anatomic imaging data using a single device in a single diagnostic session, and has opened up a new field of clinical oncologic imaging. FDG-PET/CT has been used successfully for the staging, treatment optimization, re-staging, therapy monitoring, and prognostication of uterine and ovarian cancers as well as various malignant tumors. The present review discusses the current role of FDG-PET/CT in the management of gynecologic malignancies, focusing on its usefulness and limitations for imaging such patients.
authors.affiliation: Department of Radiology, Kobe University Graduate School of Medicine, 7-5-2 Kusunoki-cho, Chuo-ku, Kobe, 650-0017, Japan, kazu10041976@yahoo.co.jp.
authors.forename: Kazuhiro
authors.initials: K
authors.lastname: Kitajima
authors.forename: Yasuhiko
authors.initials: Y
authors.lastname: Ebina
authors.forename: Kazuro
authors.initials: K
authors.lastname: Sugimura
mesh_terms: D005260:Female; D019788:Fluorodeoxyglucose F18; D005544:Forecasting; D005833:Genital Neoplasms, Female / Q000175:diagnosis*; D005836:Genitalia, Female / Q000000981:diagnostic imaging; D006801:Humans; D064847:Multimodal Imaging / Q000639:trends*; D049268:Positron-Emission Tomography / Q000639:trends*; D019275:Radiopharmaceuticals; D014057:Tomography, X-Ray Computed / Q000639:trends*
chemical_list: D019275:Radiopharmaceuticals; D019788:Fluorodeoxyglucose F18
references.citation: Int J Radiat Oncol Biol Phys. 2007 Jan 1;67(1):91-6
references.pmid: 17189066
references.citation: Mol Imaging Biol. 2008 Mar-Apr;10(2):107-13
references.pmid: 18097724
references.citation: Nucl Med Commun. 2011 Jul;32(7):549-53
references.pmid: 21407140
references.citation: Radiology. 2004 Nov;233(2):433-40
references.pmid: 15516617
references.citation: J Clin Oncol. 2004 Jun 1;22(11):2167-71
references.pmid: 15169804
references.citation: Eur J Nucl Med Mol Imaging. 2010 Aug;37(8):1490-8
references.pmid: 20386901
references.citation: J Nucl Med. 2003 Mar;44(3):353-8
references.pmid: 12621000
references.citation: Cancer. 2006 Feb 15;106(4):914-22
references.pmid: 16411226
references.citation: Eur J Radiol. 2012 Nov;81(11):3511-7
references.pmid: 22305013
references.citation: Eur J Nucl Med Mol Imaging. 2004 Feb;31(2):196-201
references.pmid: 15129701
references.citation: J Nucl Med. 2008 Feb;49(2):201-5
references.pmid: 18199612
references.citation: Eur J Radiol. 2012 May;81(5):1002-6
references.pmid: 21349672
references.citation: Neoplasma. 2008;55(5):437-41
references.pmid: 18665755
references.citation: J Nucl Med. 2010 Mar;51(3):360-7
references.pmid: 20150275
references.citation: Int J Radiat Oncol Biol Phys. 2008 Nov 15;72(4):1134-9
references.pmid: 18472358
references.citation: Int J Gynecol Cancer. 2014 Mar;24(3):454-60
references.pmid: 24463640
references.citation: J Clin Oncol. 2010 Apr 20;28(12):2108-13
references.pmid: 20308664
references.citation: Int J Gynecol Cancer. 2012 Sep;22(7):1163-9
references.pmid: 22810969
references.citation: Nucl Med Commun. 2008 Dec;29(12):1046-51
references.pmid: 18987524
references.citation: Eur J Nucl Med Mol Imaging. 2014 Jan;41(1):79-88
references.pmid: 24085502
references.citation: Gynecol Oncol. 2013 Feb;128(2):397-404
references.pmid: 23107613
references.citation: Eur J Nucl Med Mol Imaging. 2008 Oct;35(10):1912-20
references.pmid: 18682935
references.citation: Gynecol Oncol. 2007 Apr;105(1):145-9
references.pmid: 17229460
references.citation: Eur J Nucl Med Mol Imaging. 2005 Jul;32(7):757-63
references.pmid: 15772859
references.citation: Eur J Radiol. 2011 Nov;80(2):e98-103
references.pmid: 20688446
references.citation: Abdom Imaging. 2008 Jan-Feb;33(1):112-8
references.pmid: 17404789
references.citation: PLoS One. 2014 Mar 06;9(6):e90844
references.pmid: 24603857
references.citation: Gynecol Oncol. 2003 Sep;90(3):519-28
references.pmid: 13678719
references.citation: J Nucl Med. 2009 Oct;50(10):1598-604
references.pmid: 19759112
references.citation: Eur J Nucl Med Mol Imaging. 2008 Aug;35(8):1439-48
references.pmid: 18418592
references.citation: Eur J Nucl Med Mol Imaging. 2008 Feb;35(2):287-95
references.pmid: 17943281
references.citation: Nucl Med Commun. 2007 Aug;28(8):589-95
references.pmid: 17625380
references.citation: Gynecol Oncol. 2010 Mar;116(3):389-94
references.pmid: 19926121
references.citation: J Clin Oncol. 2005 Oct 20;23(30):7445-53
references.pmid: 16157939
references.citation: Eur J Radiol. 2009 Jul;71(1):164-74
references.pmid: 18378417
references.citation: Eur J Nucl Med Mol Imaging. 2014 Mar;41(3):446-51
references.pmid: 24221243
references.citation: Radiology. 2006 Jan;238(1):272-9
references.pmid: 16304090
references.citation: Gynecol Oncol. 2013 Nov;131(2):389-94
references.pmid: 23994535
references.citation: Gynecol Oncol. 2008 Aug;110(2):172-8
references.pmid: 18499238
references.citation: Gynecol Oncol. 2002 Oct;87(1):90-7
references.pmid: 12468348
references.citation: Eur J Nucl Med Mol Imaging. 2005 May;32(5):549-56
references.pmid: 15599527
references.citation: Eur J Nucl Med Mol Imaging. 2007 Apr;34(4):480-6
references.pmid: 17089122
references.citation: Eur J Nucl Med Mol Imaging. 2013 Jan;40(1):52-60
references.pmid: 22968401
references.citation: Nucl Med Commun. 2014 Feb;35(2):144-50
references.pmid: 24177043
references.citation: Radiology. 2013 Dec;269(3):857-69
references.pmid: 24009348
references.citation: J Nucl Med. 2014 Apr;55(4):551-8
references.pmid: 24491410
references.citation: Abdom Imaging. 2004 May-Jun;29(3):398-403
references.pmid: 15354347
references.citation: Radiology. 2008 Aug;248(2):599-605
references.pmid: 18539894
references.citation: J Nucl Med. 2003 Jul;44(7):1051-6
references.pmid: 12843219
references.citation: JAMA. 2007 Nov 21;298(19):2289-95
references.pmid: 18029833
references.citation: Cancer. 2007 Oct 15;110(8):1738-44
references.pmid: 17786947